[1] LU X, LI R, YAN X. Airway hyperresponsiveness development and the toxicity of PM2.5[J]. Environ Sci Pollut Res Int, 2021, 28(6):6374-6391. [2] 张开月, 李小琴, 姚庆兵, 等. 2017-2019年扬州市大气污染物与儿童呼吸系统门诊量的时间序列分析[J]. 环境监控与预警, 2021, 13(5):67-70, 123. [3] HEUSINKVELD H J, WAHLE T, CAMPBELL A, et al. Neurodegenerative and neurological disorders by small inhaled particles[J]. Neurotoxicology, 2016, 56:94-106. [4] NUNES C, PEREIRA A M, MORAIS-ALMEIDA M. Asthma costs and social impact[J]. Asthma Res Pract, 2017, 3:1. [5] LIANG L L, ENGLING G, DU Z Y, et al. Seasonal variations and source estimation of saccharides in atmospheric particulate matter in Beijing, China[J]. Chemosphere, 2016, 150:365-377. [6] CHEN R, HU B, LIU Y, et al. Beyond PM2.5:the role of ultrafine particles on adverse health effects of air pollution[J]. Biochim Biophys Acta, 2016, 1860(12):2844-2855. [7] ZHU J, ZHAO Y M, GAO Y Z, et al. Effects of different components of PM2.5 on the expression levels of NF-κB family gene mRNA and inflammatory molecules in human macrophage[J]. Int J Environ Res Public Heal, 2019, 16(8):1408. [8] ALI M U, LIU G J, YOUSAF B, et al. A systematic review on global pollution status of particulate matter-associated potential toxic elements and health perspectives in urban environment[J]. Environ Geochem Heal, 2019, 41(3):1131-1162. [9] XU M, CAO F L, ZHANG Y F, et al. Tanshinone ⅡA therapeutically reduces LPS-induced acute lung injury by inhibiting inflammation and apoptosis in mice[J]. Acta Pharmacol Sin, 2015, 36(2):179-187. [10] 高辉, 杨丰鹤, 高炜, 等. 丹参酮ⅡA对慢性阻塞性肺病急性加重期肺功能和TLR4/NF-κB信号通路的影响[J]. 西北药学杂志, 2020, 35(6):930-934. [11] 陈东亚, 赵荣, 陈新霞, 等. 丹参酮ⅡA磺酸钠对环境细颗粒物所致大鼠肺部炎性损伤的影响[J]. 环境与职业医学, 2021, 38(2):152-156. [12] COHEN A J, BRAUER M, BURNETT R, et al. Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution:an analysis of data from the Global Burden of Diseases Study 2015[J]. Lancet, 2017, 389(10082):1907-1918. [13] BU X, XIE Z L, LIU J, et al. Global PM2.5-attributable health burden from 1990 to 2017:estimates from the Global Burden of disease study 2017[J]. Environ Res, 2021, 197:111123. [14] RICE M B, LJUNGMAN P L, WILKER E H, et al. Long-term exposure to traffic emissions and fine particulate matter and lung function decline in the Framingham heart study[J]. Am J Respir Crit Care Med, 2015, 191(6):656-664. [15] 林在生, 王恺, 林少凯, 等. PM2.5对小学生肺功能影响的调查研究[J]. 中国预防医学杂志, 2019, 20(12):1167-1170. [16] 邓元荣, 李泳宁, 黄晓敏, 等. 大气细颗粒物吸入动物模型建立及适用性评价[J]. 中国比较医学杂志, 2016, 26(9):42-49. [17] 张亚平, 张广平, 苏萍, 等. 不同途径吸入脂多糖致大鼠急性肺炎模型的优选[J]. 中国实验方剂学杂志, 2018, 24(7):82-88. [18] GU X Y, CHU X, ZENG X L, et al. Effects of PM2.5 exposure on the Notch signaling pathway and immune imbalance in chronic obstructive pulmonary disease[J]. Environ Pollut, 2017, 226:163-173. [19] 朱敏立, 胡美, 司少艳, 等. 空气污染暴露对大鼠呼吸系统炎症反应的影响及机制研究[J]. 解放军医药杂志, 2021, 33(10):6-9. [20] 李嫚, 王振军, 刘洁云, 等. 丹参酮ⅡA磺酸钠注射液对心肌缺血再灌注大鼠心功能和免疫反应的调节作用[J]. 中国临床解剖学杂志, 2019, 37(4):397-402. [21] 范忠祥, 胡波, 胡云海, 等. 丹参酮治疗对过敏性紫癜患儿凝血功能、炎症因子及免疫功能的影响[J]. 海南医学院学报, 2019, 25(4):280-283, 287. [22] RAMANATHAN M, LONDON N R, THARAKAN A, et al. Airborne particulate matter induces nonallergic eosinophilic sinonasal inflammation in mice[J]. Am J Respir Cell Mol Biol, 2017, 57(1):59-65. [23] HAN D, YBANEZ M D, AHMADI S, et al. Redox regulation of tumor necrosis factor signaling[J]. Antioxid Redox Signal, 2009, 11(9):2245-2263. [24] FATHY S A, MOHAMED M R, ALI M A M, et al. Influence of IL-6, IL-10, IFN-γ and TNF-α genetic variants on susceptibility to diabetic kidney disease in type 2 diabetes mellitus patients[J]. Biomarkers, 2019, 24(1):43-55. [25] 王强, 董年. 大气颗粒物急性暴露对C57BL/6小鼠肺脏病理改变和气道上皮细胞IL-6和IL-8表达的影响[J]. 中国病理生理杂志, 2021, 37(1):128-133. [26] WANG J, ZHANG W J, XIONG W, et al. PM2.5 stimulated the release of cytokines from BEAS-2B cells through activation of IKK/NF-κB pathway[J]. Hum Exp Toxicol, 2019, 38(3):311-320. [27] DAI P, SHEN D, SHEN J, et al. The roles of Nrf2 and autophagy in modulating inflammation mediated by TLR4-NFκB in A549 cell exposed to layer house particulate matter 2.5(PM2.5)[J]. Chemosphere, 2019, 235:1134-1145. [28] BALDWIN A S. Series introduction:the transcription factor NF-kappaB and human disease[J]. J Clin Invest, 2001, 107(1):3-6. [29] KARIN M, BEN-NERIAH Y. Phosphorylation meets ubiquitination:the control of NF-[kappa]B activity[J]. Annu Rev Immunol, 2000, 18:621-663. [30] 吴筱霓, 刘伟, 何玉华, 等. 丹参酮ⅡA药理作用研究进展[J]. 中国药业, 2020, 29(21):93-97. [31] SONG Z, FENG J, ZHANG Q, et al. Tanshinone ⅡA protects against cerebral ischemia reperfusion injury by regulating microglial activation and polarization via NF-κB pathway[J]. Front Pharmacol, 2021, 12:641848. [32] 李春陵, 朱静雯, 王里. 丹参酮ⅡA磺酸钠对慢性阻塞性肺疾病气道重塑大鼠PPARγ、NF-κB的影响研究[J]. 贵州医药, 2016, 40(5):466-468. [33] 姜明, 乔锐. 丹参酮ⅡA磺酸钠注射液联合贝那普利治疗冠心病心力衰竭的临床疗效及其对心功能、血液流变学的影响[J]. 实用心脑肺血管病杂志, 2018, 26(10):96-99. [34] 姜海瑞, 郝利国. 丹参酮ⅡA磺酸钠注射液与舒血宁注射液治疗气虚血瘀型冠心病心绞痛的效果比较[J]. 中国医药导报, 2019, 16(1):145-148, 152. |